CONTROL BIONICS LIMITED (CBL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CBL - CONTROL BIONICS LIMITED

FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Technology Hardware & Equipment
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.68

15 Sep
2021

-0.010

OPEN

$0.68

-1.45%

HIGH

$0.68

18,943

LOW

$0.67

TARGET
$1.42 108.8% upside
OTHER COMPANIES IN THE SAME SECTOR
ELX . PGC . AHZ . COH . FPH . IPD . LHC . NAN . RMD . SOM . HLA . MX1 . CAT . VHT . ONE . IDX . PME . CSX . 4DX . BRN . EMV . UBI . LDX . RAP . RVA . MEB . IME . PCK . CMP . CYC . IMR . VTI . OVN . EYE . AT1 .
FNARENA'S MARKET CONSENSUS FORECASTS
CBL: 1
Title FY20
Actual
FY21
Actual
FY22
Forecast
FY23
Forecast
EPS (cps) xxx - 4.3 - 4.1 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A N/A xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 08/09 - 1.5c

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2021 FactSet UK Limited. All rights reserved
Title 201920202021
EPS Basic xxxxxx-4.3
DPS All xxxxxx0.0
Sales/Revenue xxxxxx4.0 M
Book Value Per Share xxxxxx20.6
Net Operating Cash Flow xxxxxx-4.0 M
Net Profit Margin xxxxxx-89.39 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021
Return on Assets xxxxxx-28.75 %
Return on Equity xxxxxx-31.03 %
Return on Total Capital xxxxxx-28.17 %
Capex xxxxxx0.1 M
Capex % of Sales xxxxxx1.34 %
Free Cash Flow ex dividends xxxxxx-4.0 M

Return on Assets

Return on Equity

Return on Total Capital

Capex

Capex % of Sales

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

27/08/2021

1

Add

$1.42

108.82%

The FY21 results for Control Bionics exceeded forecasts. Morgans believes the business can drive higher sales in FY22, having two recent distribution arrangements.

One is with DNR Wheels for entry to Singapore and the other Numotion in several US states. The company will continue to invest in future product development and build a sales and marketing team in the US. Speculative Buy retained. Target is $1.42.

FORECAST
Morgans forecasts a full year FY22 dividend of 0.00 cents and EPS of minus -4.10 cents.
Morgans forecasts a full year FY23 dividend of 0.00 cents and EPS of minus -4.70 cents.

CBL STOCK CHART